Skip to Main Content
Title
Strategies for containing drug costs: implications for a Medicare benefit.
First Author
Cook, Anna E
Date of Pub
1999 Spring
Pages
29-37
Volume
20
Issue
3
Other Authors
N/A
Abstract
As policymakers consider adding a prescription drug benefit to Medicare, cost containment will be an important issue. This article discusses strategies to hold down the prices paid for prescription drugs. Within the private sector these include the use of formularies, the emergence of pharmaceutical benefit management companies, and the expansion of mail order pharmacies. In the Federal Government, costs are contained by the Medicaid drug rebate and the Federal Supply Schedule (FSS) of prices. Since Medicare beneficiaries constitute a large share of the prescription drug market, getting access to FSS prices may not be feasible. A flat rebate is one alternative.
Abstract Continued
N/A
MeSH
Drug Costs : Insurance, Pharmaceutical Services : Aged : Cost Control/methods : Fee Schedules : Human : Medicaid/economics : Medicare/economics : Policy Making : Private Sector : United States
NTIS Number
PB2000-102916